Simulated home treatment of depression with nortriptyline.

Prog Neuropsychopharmacol Biol Psychiatry

University of Texas Harris County Psychiatric Center, Department of Psychiatry, Houston.

Published: April 1991

1. Twenty-two patients hospitalized for treatment of depression were treated under conditions simulating those of home treatment. 2. Full doses of nortriptyline, from 100 to 150 mg/day, were started after baseline observations were made. 3. Two patients were dropped from the study, one for orthostatic hypotension, one for an aberrant response to nortriptyline. Two additional patients developed orthostasis which was easily managed. Otherwise no unusual side effects were noted. 4. After six days of treatment, 9 of 20 patients showed significant improvement with an overall reduction in scores on the Hamilton Depression Scale of 49% for the entire group. 5. Using the weight-adjusted dosage schedule, 18 of the 21 patients attained plasma concentrations of nortriptyline within the presumed therapeutic range; however, no clear relationship could be established between plasma concentrations and clinical response. 6. With proper selection of patients, it should be possible to treat at home some patients who currently are considered to require hospitalization.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0278-5846(91)90041-xDOI Listing

Publication Analysis

Top Keywords

treatment depression
8
plasma concentrations
8
patients
7
simulated treatment
4
nortriptyline
4
depression nortriptyline
4
nortriptyline twenty-two
4
twenty-two patients
4
patients hospitalized
4
hospitalized treatment
4

Similar Publications

Exploring the depths: correlates of depression among seafarers in Mumbai, India.

Ann Ig

March 2025

Department of Global Public Health Policy and Governance, Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India.

Background: Seafarers experience unique challenges related to their profession, including risks for mental health. The present study explored the correlates of depression among seafarers in India.

Methods: Following ethics clearance, this cross-sectional study was conducted at an international shipping company in Mumbai, India.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined the impact of different autonomous dialysis methods on patients' lives in France, focusing on work, social activities, and quality of life.
  • About 33% of the participants held paid jobs, with varying levels of physical activity reported, while most patients experienced minimal issues with mobility, self-care, and overall health status.
  • The findings indicate that while dialysis significantly influences professional and social aspects of life, differences between the various dialysis methods were limited.
View Article and Find Full Text PDF

Comorbidities of hypothyroidism.

Curr Med Res Opin

March 2025

Merck Healthcare KGaA, Darmstadt, Germany.

Hypothyroidism is a relatively common condition that may affect as many as 10% of the population worldwide when its overt and subclinical presentations are considered. Important clinical comorbidities are highly prevalent in people with hypothyroidism and diminish quality of life and functional status in a manner that is proportional to the number of comorbidities present and their severity. This article reviews the common comorbidities of hypothyroidism, as reported in the literature.

View Article and Find Full Text PDF

Ferroptosis, pathogenesis and therapy in AS co-depression disease.

Front Pharmacol

February 2025

School of Rehabilitation Medicine, Gannan Medical University, Ganzhou, Jiangxi, China.

Atherosclerosis (AS)-related cardiovascular disease and depression are often comorbid, with patients with cardiovascular disease facing an increased risk of depression, which worsens AS. Both diseases are characterized by oxidative stress and lipid metabolism disorders. Ferroptosis, a form of cell death characterized by iron overload and harmful lipid peroxide accumulation, is found in various diseases, including AS and depression.

View Article and Find Full Text PDF

Background: We previously identified a cognitive biotype of depression characterized by dysfunction of the brain's cognitive control circuit, comprising the dorsolateral prefrontal cortex (dLPFC) and dorsal anterior cingulate cortex (dACC), derived from functional magnetic resonance imaging (fMRI). We evaluate these circuit metrics as personalized predictors of antidepressant remission.

Methods: We undertook a secondary analysis of data from the international Study to Predict Optimized Treatment in Depression (iSPOT-D) for 159 patients who completed fMRI during a GoNoGo task, 8 weeks treatment with one of three study antidepressants and who were assessed for remission status (Hamilton Depression Rating Scale score of ≤ 7).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!